Writers challenge points made in article about antiemetic therapy.
Carroll-Johnson
Rose Mary
RM
D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D017277:Drug Approval; D017829:Granisetron / Q000627:therapeutic use; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use; D009325:Nausea / Q000517:prevention & control*; D017294:Ondansetron / Q000008:administration & dosage* / Q000009:adverse effects; D011807:Quinolizines / Q000009:adverse effects / Q000627:therapeutic use; D014481:United States
D000932:Antiemetics; D000970:Antineoplastic Agents; D017829:Granisetron; D007211:Indoles; D017294:Ondansetron; D011807:Quinolizines; C060344:dolasetron